NYSE Volume Active Stocks are - DUK, GE, C, JEF, XLS*
01.01.70
Duke Energy Corporation (NYSE: DUK) slid -0.82%, to close at $20.64 and its overall traded volume was 41.96M shares during the last session with the total traded volume of 15.75M shares. DUK opened at $20.72 and is trading within the range of $20.35-$20.72. The 52-week range of the stock is $16.87-$20.85. At current market price, the market capitalization of the company stands at $27.22B and it has 1.32B outstanding shares.
Duke Energy Corporation (Duke Energy) is an energy company primarily located in the Americas. Duke Energy operates in the United States primarily through its direct and indirect wholly-owned subsidiaries. Duke Energy operates in three segments: U. S. Franchised Electric and Gas (USFE&G), Commercial Power and International Energy. USFE&G segment generates, transmits, distributes and sells electricity in central and western North Carolina, western South Carolina, southwestern Ohio, central, north central and southern Indiana, and
Source: Retirement Planning
GE Healthcare's IN Cell Analyzer Image Competition Inspires Through the Beauty ...
01.01.70
Today announced that voting for
the 2011 IN Cell Analyzer Image Competition is now open at gelifesciences.com/incellcompetition.
Both scientists and the wider public are invited to choose their
favourite from 30 shortlisted images submitted by researchers worldwide.
When making their selection, voters can consider the beauty of the
image, their interest in the science behind it, or a combination of the
two. The winning entrants from each region (Americas, Europe and
Asia/Rest of World) will be invited to New York to see their images
projected on NBC's high definition screen in Times Square.
Carmen Laethem, Aerie Pharmaceuticals, a previous winner and a judge on
the 2011 shortlisting panel, said, "The images of cells that scientists
produce every day on the IN Cell Analyzer can be captivatingly
beautiful, some reminiscent of scenes from nature or even evoking the
visual style of artists such as Jackson Pollock or Miro. Behind that
beauty lies valuable data which enables researchers to, for example,
better understand the mechanisms behind disease at the cellular level or
conduct early screens for potential new therapies."
Source: MarketWatch (press release)